|
|
DSpace at RU >
Browsing by Author Wit, R. de
Showing results 1 to 14 of 14
| Full Text | Issue Date | Title | Author(s) | | 2008 | European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): part II. | Krege, S.; Beyer, J.; Souchon, R.; Albers, P.; Albrecht, W., et al |
| 2008 | European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus group (EGCCCG): part I. | Krege, S.; Beyer, J.; Souchon, R.; Albers, P.; Albrecht, W., et al |
| 2005 | Evaluation of early pelvic floor physiotherapy on the duration and degree of urinary incontinence after radical retropubic prostatectomy in a non-teaching hospital. | Cornel, E.B.; Wit, R. de; Witjes, J.A. |
| 2005 | Intensive induction chemotherapy with C-BOP/BEP for intermediate- and poor-risk metastatic germ cell tumours (EORTC trial 30948). | Fossa, S.D.; Paluchowska, B.; Horwich, A.; Kaiser, G.; Mulder, P.H.M. de, et al |
| 2004 | Osteonecrosis in patients with testicular tumours treated with chemotherapy. | Berkmortel, F. van den; Wit, R. de; Rooy, J.W.J. de; Mulder, P.H.M. de |
| 2004 | European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG). | Schmoll, H.J.; Souchon, R.; Krege, S.; Albers, P.; Beyer, J., et al |
| 1997 | Randomized trial of Bleomycin, Etoposide, and Cisplatin compared with Bleomycin, Etoposide, and carboplatin in good-prognosis metastatic nonseminomatous germ cell cancer : a multiinstitutional medical research council/European organization for research and treatment of cancer trial | Horwich, A.; Sleijfer, D.Th.; FossÄ, S.D.; Kaye, S.B.; Oliver, R.T.D., et al |
| 1997 | Treatment in germ cell tumors, state of the art | Tjan-Heijnen, V.C.; Oosterhof, G.O.N.; Wit, R. de; Mulder, P.H.M. de |
| 1996 | Experience with dose and schedule variations in germ cell tumors | Mulder, P.H.M. de; Wit, R. de |
| 1996 | Richtlijn gebruik taxoiden in de oncologische praktijk | Willemse, P.H.B.; Bokkel Huinink, W.W. ten; Wit, R. de; Punt, C.J.A.; Vermorken, A.J.M., et al |
| 1996 | Analysis of cumulative probabilities shows that the efficacy of 5HT3 antagonist prophylaxis is not maintained | Wit, R. de; Schmitz, P.I.M.; Verweij, J.; Boer-Dennert, M. de; Mulder, P.H.M. de, et al |
| 1996 | Randomized placebo-controlled trial of granulocyte-macrophage colony-stimulating factor in patients with chemotherapy-related febrile neutropenia | Vellenga, E.; Uyl-de Groot, C.A.; Wit, R. de; Keizer, H.J.; Löwenberg, B., et al |
| 1995 | Four cycles of BEP versus an alternating regime of PVB and BEP in patients with poor-prognosis metastatic testicular non-seminoma; a randomised study of the EORTC Genitourinary Tract Cancer Cooperative Group | Wit, R. de; Stoter, G.J.; Sleijfer, D.Th.; Kaye, S.B.; Mulder, P.H.M. de, et al |
| 1995 | Randomized placebo controlled trial of GM-CSF in patients with chemotherapy related febrile neutropenia | Vellenga, E.; Uyl-de Groot, C.A.; Wit, R. de; Keizer, H.J.; Lowenberg, B., et al |
Showing results 1 to 14 of 14
|